Showing codes C8926 (Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report) — C9035 (Injection, aripiprazole lauroxil (aristada initio), 1 mg)

C8926 - Tee w or w/o fol w/cont,cong
Long description: Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C8927 - Tee w or w/o fol w/cont, mon
Long description: Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis
Code added date: 20080101.
Code effective date: 20080101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C8928 - Tte w or w/o fol w/con,stres
Long description: Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report
Code added date: 20080101.
Code effective date: 20090101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C8929 - Tte w or wo fol wcon,doppler
Long description: Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography
Code added date: 20090101.
Code effective date: 20090101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C8930 - Tte w or w/o contr, cont ecg
Long description: Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision
Code added date: 20090101.
Code effective date: 20090101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C8931 - Mra, w/dye, spinal canal
Long description: Magnetic resonance angiography with contrast, spinal canal and contents
Code added date: 20101001.
Code effective date: 20101001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C8932 - Mra, w/o dye, spinal canal
Long description: Magnetic resonance angiography without contrast, spinal canal and contents
Code added date: 20101001.
Code effective date: 20101001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C8933 - Mra, w/o&w/dye, spinal canal
Long description: Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents
Code added date: 20101001.
Code effective date: 20101001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C8934 - Mra, w/dye, upper extremity
Long description: Magnetic resonance angiography with contrast, upper extremity
Code added date: 20101001.
Code effective date: 20101001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C8935 - Mra, w/o dye, upper extr
Long description: Magnetic resonance angiography without contrast, upper extremity
Code added date: 20101001.
Code effective date: 20101001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C8936 - Mra, w/o&w/dye, upper extr
Long description: Magnetic resonance angiography without contrast followed by with contrast, upper extremity
Code added date: 20101001.
Code effective date: 20101001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C8937 - Cad breast mri
Long description: Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)
Code added date: 20190101.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C8957 - Prolonged iv inf, req pump
Long description: Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
Code added date: 20060101.
Code effective date: 20060101.
Pricing Indicator Code(s): 99 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9014 - Injection, cerliponase alfa
Long description: Injection, cerliponase alfa, 1 mg
Code added date: 20180101.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9015 - C-1 esterase, haegarda
Long description: Injection, c-1 esterase inhibitor (human), haegarda, 10 units
Code added date: 20180101.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9016 - Inj, triptorelin ext rel
Long description: Injection, triptorelin extended release, 3.75 mg
Code added date: 20180101.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9021 - Injection, obinutuzumab
Long description: Injection, obinutuzumab, 10 mg
Code added date: 20140401.
Code effective date: 20150101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9022 - Injection, elosulfase alfa
Long description: Injection, elosulfase alfa, 1mg
Code added date: 20140701.
Code effective date: 20150101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9023 - Inj testosterone undecanoate
Long description: Injection, testosterone undecanoate, 1 mg
Code added date: 20141001.
Code effective date: 20150101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9024 - Inj, daunorubicin-cytarabine
Long description: Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
Code added date: 20180101.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9025 - Injection, ramucirumab
Long description: Injection, ramucirumab, 5 mg
Code added date: 20141001.
Code effective date: 20160101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9026 - Injection, vedolizumab
Long description: Injection, vedolizumab, 1 mg
Code added date: 20141001.
Code effective date: 20160101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9027 - Injection, pembrolizumab
Long description: Injection, pembrolizumab, 1 mg
Code added date: 20150101.
Code effective date: 20160101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9028 - Inj. inotuzumab ozogamicin
Long description: Injection, inotuzumab ozogamicin, 0.1 mg
Code added date: 20180101.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9029 - Injection, guselkumab
Long description: Injection, guselkumab, 1 mg
Code added date: 20180101.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9030 - Inj copanlisib
Long description: Injection, copanlisib, 1 mg
Code added date: 20180701.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9031 - Lutetium lu 177 dotatate, tx
Long description: Lutetium lu 177, dotatate, therapeutic, 1 mci
Code added date: 20180701.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9032 - Voretigene neparvovec-rzyl
Long description: Injection, voretigene neparvovec-rzyl, 1 billion vector genome
Code added date: 20180701.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9033 - Inj, akynzeo
Long description: Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
Code added date: 20181001.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9034 - Injection, dexamethasone 9%
Long description: Injection, dexamethasone 9%, intraocular, 1 mcg
Code added date: 20181001.
Code effective date: 20190101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9035 - Injection, aristada initio
Long description: Injection, aripiprazole lauroxil (aristada initio), 1 mg
Code added date: 20190101.
Code effective date: 20191001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF